Guillermo Philipps
Neurology with Special Qualifications in Child Neurology · Port Charlotte, FLNPI 1992943781
Payments from drug & device makers
Across 85 payments — averaging $46.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- PTC Therapeutics, Inc.$720
- Livanova USA, Inc.$459
- UCB, Inc.$414
- SK Life Science, Inc.$344
- Catalyst Pharmaceuticals, Inc.$238
- Acadia Pharmaceuticals Inc$217
- plus $2K from 27 others
What the payments were for
- Consulting fees$72018%
- Speaking & faculty fees$2005%
- Food & beverage$2,97076%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| PTC Therapeutics, Inc. | 1 | $720 |
| Livanova USA, Inc. | 7 | $459 |
| UCB, Inc. | 11 | $414 |
| SK Life Science, Inc. | 3 | $344 |
| Catalyst Pharmaceuticals, Inc. | 8 | $238 |
| Acadia Pharmaceuticals Inc | 2 | $217 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 2 | $191 |
| Sunovion Pharmaceuticals Inc. | 10 | $148 |
| Genentech USA, Inc. | 2 | $138 |
| Supernus Pharmaceuticals, Inc. | 2 | $130 |
| Sumitomo Pharma America, Inc. | 1 | $123 |
| Jazz Pharmaceuticals Inc. | 4 | $113 |
| Biogen | 1 | $110 |
| Ironshore Pharmaceuticals Inc. | 5 | $78 |
| Aucta Pharmaceuticals, Inc. | 3 | $55 |
| Otter Pharmaceuticals, LLC | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Tris Pharma Inc | 2 | $37 |
| Novartis | 2 | $33 |
| Aquestive Therapeutics, Inc. | 2 | $31 |
| ITF Therapeutics LLC | 1 | $27 |
| Corium, LLC | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
| Nobelpharma America, LLC | 1 | $25 |
| Sarepta Therapeutics, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $23 |
| Soleno Therapeutics, Inc. | 1 | $21 |
| Neurelis, Inc. | 1 | $19 |
| Springworks Therapeutics, Inc. | 1 | $18 |
| Zogenix Inc. | 1 | $17 |
| Saol Therapeutics Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $14 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,931 in reported general payments places this provider in the 45th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LamictalLamotrigine | 20 | $26,935 |
| VimpatLacosamide | 14 | $16,453 |
| Lacosamide | 13 | $464 |
| Levetiracetam | 37 | $286 |
| Fluvoxamine Maleate | 12 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| UCB, Inc.Vimpat | $414 | $16,45314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
Other neurology with special qualifications in child neurology in Port Charlotte
- Britt StroudPort Charlotte$13K
- Paul WinnerWest Palm Beach$18.4M
- James RenfroeGulf Breeze$2.9M
- Walter MartinezWest Palm Beach$1.9M
- Weldon MauneyGulf Breeze$1.3M
- Ian MillerMiami$1.1M
- Jose FerreiraTampa$876K
- Ronald DavisWinter Park$873K
- Peter KangGainesville$607K
- Omer Abdul HamidOrlando$467K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.